| Name: | Fluticasone EP Impurity A |
| Catalogue No. | VL1000006 |
| CAS No. | 65429-42-7 |
| Molecular Formula | C24H30F2O6 |
| Molecular Weight | 452.49 |
| Status | In-stock |
| IUPAC Name | (6α,11β,16α,17α)-6,9-Difluoro-11-hydroxy-16-methyl-3-oxo-17-(1-oxopropoxy)-androsta-1,4-diene-17-carboxylic Acid |
| Synonyms | Fluticasone Carboxylic Acid Propionate |
| Description | Fluticasone EP Impurity A (CAS No: 65429-42-7) or (6α,11β,16α,17α)-6,9-Difluoro-11-hydroxy-16-methyl-3-oxo-17-(1-oxopropoxy)-androsta-1,4-diene-17-carboxylic Acid is an impurity of Fluticasone. Fluticasone is used to treat symptoms, unquiet or liquid nose, or alternative symptoms caused by allergic rhinitis. it's conjointly accustomed to treat nasal polyps in adults. |
| References | “Sci-Hub | the Human Pharmacology of Fluticasone Propionate | 10.1016/S0954-6111(08)80004-2.” Hkvisa.net, 2022, sci-hub.hkvisa.net/10.1016/S0954-6111(08)80004-2. |
